Coinbase
COIN
Meta Platforms
META
Apple
AAPL
Amazon
AMZN
Lennar Corp
LEN
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 26.600
- 0.0000.00%
Trading Dec 3 10:58 ET
5.03BMarket Cap-10991P/E (TTM)
27.080High26.320Low281.23KVolume26.420Open26.600Pre Close7.50MTurnover0.22%Turnover RatioLossP/E (Static)188.99MShares44.32052wk High-4.09P/B3.42BFloat Cap21.62052wk Low--Dividend TTM128.47MShs Float73.500Historical High--Div YieldTTM2.86%Amplitude4.980Historical Low26.679Avg Price1Lot Size
BridgeBio Pharma Key Stats
EPS
According to the latest financial report of BridgeBio Pharma, the latest earnings per share (TTM) for the company is -0.86. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about BridgeBio Pharma's free cash flow? The latest report shows it as -182.30M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BridgeBio Pharma shows that the company's current ratio is 3.19, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BridgeBio Pharma, the quick ratio is 1.92, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of BridgeBio Pharma? The latest ROE figure is -108.26%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BridgeBio Pharma, the total asset return on investment (ROA) is -22.21%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BridgeBio Pharma's latest financial report to see how their gross margin is doing - currently at 78.11%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BridgeBio Pharma, the net profit margin is -6.01K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.